Drugs / F0434
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01263132 | Feb 2008 → Feb 2010 | diabetic polyneuropathy, polyneuropathy | Merck KGaA, Darmstadt, Germany | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | F0434 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01263132 ↗ |
| Route | Oral | “F0434 will be administered orally” NCT01263132 ↗ |